Physician profile
Mohammad Seyyedi
NPI 1487041653
$3,126.06
in general payments reported to CMS, 2019-2025
20 companies · $770 in 2025
The $770 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $67.42 · 2021: $58.04 · 2022: $350 · 2023: $71.27 · 2024: $1,471 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Travel and Lodging: $981 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.04 |
| Travel and Lodging | $980.78 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $1,169.67 | 2019-2024 | |
| Genzyme Corporation | $274.80 | 2024-2025 | |
| Stryker Corporation | $256.54 | 2019-2022 | |
| Integra Lifesciences Corporation | $246.84 | 2022-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Regeneron Healthcare Solutions, INC. | $176.30 | 2020-2025 | Dupixent |
| Medtronic, INC. | $168.52 | 2022-2024 | Sinuva |
| Astrazeneca Pharmaceuticals LP | $134.55 | 2025 | |
| Cochlear Americas | $127.79 | 2019-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Glaxosmithkline, LLC. | $111.63 | 2023-2025 | Nucala |
| Optinose US, INC. | $108.30 | 2024-2025 | |
| Hikma Pharmaceuticals USA | $75.25 | 2024 | Ryaltris |
| Olympus America INC. | $71.58 | 2019 | |
| Advanced Bionics, LLC | $58.04 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $28.64 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $24.37 | 2024 | Cuvitru |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $22.76 | 2023 | Fisher & Paykel Healthcare |
| Medtronic USA, INC. | $19.14 | 2020 | |
| Inspire Medical Systems, INC. | $18.73 | 2025 | Inspire |
| Cook Medical LLC | $18.17 | 2025 | Zenith Spiral-Z |
| Baxter Healthcare | $14.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Seyyedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.